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doi:10.1016/j.ijid.2003.12.006Summary Objective: Osteomyelitis due to Candida species is an unusual but recogni-
zed entity. However, with the increasing occurrence of factors predisposing to candi-
demia and invasive candidiasis, candidal osteomyelitis is being diagnosed more
frequently. An unusual case of Candida albicans osteomyelitis is reported here, along
with a review of the published literature on previously reported cases of this disease.
Methods: Report of the case and literature review.
Results: In this case, Candida albicans was isolated from the talus; however, the
diagnosis was made after several cultures were performed. Only one other case of
Candida osteomyelitis located in foot bones was found in the review.
Conclusions: It is thought that this is the first case reported in Venezuela, and only
the second in international literature.
# 2004 Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases.Introduction
Osteomyelitis is an infection which is difficult to
treat, characterized by the progressive inflamma-
tory destruction and new bone growth.1,2 Normal
bone is highly resistant, needing a large bacterial212 6053635;
l.com (S. Mata-Essayag).
by Elsevier Ltd on behalf of Intinoculum, trauma, or the presence of a foreign body
in order to initiate infection.3,4
Although invasive candidal infections are being
encountered with increasing frequency in compro-
mized hosts, such as neonates and patients with
intravascular access devices, osteomyelitis caused
by Candida spp is a relatively rare infection.5 How-
ever, with the increasing occurrence of factors
predisposing to candidemia and invasive candidia-
sis, candidal osteomyelitis is being diagnosed moreernational Society for Infectious Diseases.
308 F. Arias et al.frequently.6—8 Fungal osteomyelitis is a complica-
tion of catheter-related fungemia, the use of illicit
drugs contaminated by Candida species, and pro-
longed neutropenia.2 Candida albicans is still the
most frequent infecting organism, although infec-
tions by species other than albicans are becoming
increasingly common.6—12
An unusual case of Candida albicans osteomye-
litis located in the right talus is reported here, along
with a review of the published literature on pre-
viously reported cases of this disease.Methods
A Medline search of the published literature from
1970 through to February 2003 was conducted along
with a bibliographic search of published articles to
identify clearly documented cases of osteomyelitis
caused by Candida species. All available data were
reviewed, including clinical presentation, labora-
tory results, therapeutic intervention and out-
comes.Case report
A 66 year-old otherwise healthy woman, non-dia-
betic, with no other risk factor for opportunistic
infections or vascular compromise in the affected
foot, was admitted to hospital. Her past medical
history was unremarkable, except for multiple past
episodes of arthritis in her hands and feet, and high
blood pressure. She had a previous history of right
ankle pain with progressive movement and walking
incapacity for which she underwent several surgical
interventions, consisting of debridement of
affected bone and later, arthrodesis of the ankle.
Bone fragments obtained in these interventions
were cultured and Candida albicans was the only
microorganism isolated each time. Despite these
results she had never been treated with antifungals
or antibiotics. At the time of hospitalization, she
complained of persistence of pain, swelling and had
loosening of surgical material. She was afebrile, and
at physical examination both ankles were swollen
and painful, especially on the inner side. Fingers of
both hands showed cubital deviation and weakness,
and there were no signs of acute arthritis.
Results of laboratory tests were as follows: WBC
count 8.0  109/l, with a normal differential; ery-
throcyte sedimentation rate (ESR) 44 mm/h; Ziehl
Neelsen of biopsy specimens showed no acid-fast
bacilli. Bone biopsy reported: chronic osteomyelitis
with acute inflammatory areas and fibrous exudate.
Special stains (Grocott) revealed hyphae and blas-toconidiae which inferred the presence of Candida
spp. Blood culture and culture on Sabouraud agar of
bone biopsy specimens yielded Candida spp; char-
acterization of isolates was established by the pro-
duction of clamydoconidia on Feo’s agar13 and by
carbon source assimilation reactions using a com-
mercial kit (API 32C AUX identification system —
bioMerieux La Blame-les-Grottes, France). Antifun-
gal susceptibility (well diffusion method)14 reported
susceptibility to fluconazole, itraconazole, terbina-
fine, ketoconazole, amphotericin B, and clotrima-
zole, but resistance to nystatin. The patient began
treatment with intravenous fluconazole at a dosage
of 200 mg/day for eight weeks, followed by treat-
ment with oral fluconazole at a dosage of 200 mg/
day for the next 12 months. A surgical debridement
was performed. After the patient completed treat-
ment with fluconazole, her ankle pain and swelling
had improved. Two years later, the patient showed
no clinical signs or symptoms of infection.Results
Seventy-seven Candida osteomyelitis case reports
published in the literature were reviewed, from
1970 to February 2003 (see Table 1). The most
affected bones were the spine in 31 cases
(40.3%), and the sternum in six cases (7.8%). Addi-
tionally, two (2.6%) costochondral, two (2.6%) fin-
ger phalanx, two (2.6%) mandibular, and one (1.3%)
of each of the following: clavicular joint, diabetic
foot, distal femur, hand, hip, lower extremities in a
premature newborn, and zygomatic bones were
described. There was only one report of Candida
osteomyelitis affecting foot bones.10
In 1987 Gathe et al.,10 reviewed all reports up to
1986 and found 53 cases, 21 of which were pediatric
cases. A decade later, in 1996, Hennequin et al.37
reviewed the world literature up to 1995 for cases of
candidal spondylodiscitis, the most common type
of Candida osteomyelitis, and found 52 cases. By
1999 five more cases were published in English
literature.27—29,35,38. McCullers28 described one
case of femoral Candida tropicals osteomyelitis
and reviewed 13 more. Hendrickx et al. (2001)18
reported six patients with candidal vertebral osteo-
myelitis, and additionally 59 cases not related to
drug abuse or surgery. The mean age was 55.8 years,
61% were men, and only eight patients had no
traditional risk factors. The most common risk fac-
tors were broad-spectrum antibiotics and central
intravenous catheters. Sixty one percent of patients
had prior documented candidemia. Miller et al.20
found 59 cases of candidal vertebral osteomyelitis
reported in the literature. Since Hendrickx and
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Table 1 Characteristics of patients with Candida osteomyelitis reported in the literature.
Author Year Number
of cases
Localization Type of Candida Treatment Outcome
Belzunegui15 2002 3 Sternocostal joints albicans — Mostly good
Malani16 2002 7 Sternal albicans Fluconazole Resolved
Marra17 2001 1 Hip bone albicans Amphoterici + fluconazole Improvement
Heald19 2001 3 Diabetic foot albicans Amphoterici Improvement
Petrikkos12 2001 2 Sternal albicans Fluconazole Improvement
kruseii Itraconazole
Hendrickx18 2001 6 Vertebral 3 albicans Fluconazole Improvement
1 glabrata Amphoterici
2 tropicalis
Miller20 2001 1 Vertebral albicans Amphoterici + fluconazole Improvement
Parry21 2001 3 Spine albicans Amphoterici + fluconazole Improvement
Wang22 2001 1 Vertebral — Amphoterici Improvement
Calvo23 2000 1 Vertebral albicans — —
Eisen24 2000 1 Vertebral tropicalis Amphoterici Resolved
Tietz25 1999 1 Phalanx guilliermondii Fluconazole Failed
Williams26 1999 3 Spine albicans Only surgica —
Turner27 1999 1 Spine albicans Amphoterici Relapse
McCullers28 1998 1 Distal femur tropicalis Amphoterici Resolved
Sanz-Rodriguez29 1998 1 Mandibular albicans Fluconazole Resolved
Belzunegui30 1997 2 — albicans — —
Flanagan31 1997 3 — albicans Fluconazole Complications
Clancy32 1997 4 Sternal albicans 2 Amphoteri B + 1 Fluconazole 3 died [mediastinitis]
1 resolved
Munk33 1997 1 Spine albicans Amphoterici Improvement
Myojin34 1997 1 Costochondral albicans Fluconazole Resolved
Arranz-Caso35 1996 1 Zygomatic bone albicans Amphoterici Improvement
Curran36 1996 1 Vertebral glabrata Amphoterici + fluconazole Resolved
Jonnalagadda6 1996 1 Vertebral albicans Amphoterici + flucytosine Improvement
Hennequin37 1996 2 Spine albicans Fluconazole Resolved
Corso38 1995 3 Spine 2 albicans
1 tropicalis — Improvement
Ferra9 1994 1 Vertebral tropicalis Amphoterici Died
Lafont8 1994 3 Vertebral albicans 2 Amphoteri B Resolved
1 Fluconazoln B
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Table 1 (Continued)
Author Year Number
of cases
Localization Type of Candida Treatment Outcome
Lasday39 1994 1 — — — —
de la Torre Lima40 1993 2 Spine albicans Amphotericin B Favorable
Mullins41 1993 1 Spine albicans Amphotericin B + fluconazole Resolved
Oleinik42 1993 1 Spine lusitaniae Flucytosine + fluconazole Resolved
Tang43 1993 1 Vertebral albicans Fluconazole Resolved
Weisse44 1993 1 Multiple tropicalis Amphotericin B + flucytosine Resolved
Owen45 1992 1 Vertebral glabrata Amphotericin B Resolved
Almekinders46 1991 1 Vertebral albicans Amphotericin B + ketoconazole Improvement
Ashman47 1991 1 Inner ear albicans — —
Edelstein48 1991 1 Sterno- albicans Amphotericin B Improvement
clavicular joint
Quindos49 1990 1 Spine albicans — —
Sugar50 1990 2 Costochondral — Fluconazole Resolved
Vertebral
Bannatyne51 1989 1 Fractured phalanx albicans Ketoconazole Resolved
Collet52 1989 2 Spine — Amphotericin B Resolved
Lamireau53 1988 1 Multifocal albicans Flucytosine Favourable
Friedman54 1987 3 Vertebral tropicalis Amphotericin B Resolved
Gathe10 1987 5 Spine parapsilosis Amphotericin B Resolved
3 Sternal 3 albicans
Foot bones tropicalis
Imahori55 1987 1 Vertebral glabrata Flucytosine Resolved
Neale7 1987 1 Vertebral albicans Amphotericin B Improved
Bruns56 1986 1 Spine glabrata and tropicalis Amphotericin B + flucytosine Resolved
Bruns57 1986 1 Spine tropicalis and Amphotericin B + flucytosine Resolved
glabrata
Estrov58 1984 1 Sternal albicans Amphotericin B + flucytosine Resolved
Hayes59 1984 1 Spine tropicalis — —
Pohjola-Sintonen60 1984 1 Spine albicans Amphotericin B + flucytosine Relapsed
Murdock61 1983 1 Hand Torulopsis holmii Amphotericin B + flucytosine Relapsed
Ward62 1983 1 Lower extremities albicans Amphotericin B Resolved
Diament63 1982 1 Spine — None Died
Dijkmans64 1982 1 Vertebral albicans Ketoconazole Resolved
Meier65 1982 2 Mandibular albicans — —
Gustke66 1981 1 — glabrata Amphotericin B Resolved
Thurston67 1981 1 Spine glabrata Amphotericin B + Resolved
Flucytosine
Candida albicans osteomyelitis: case report and literature review 311
Sh
ai
kh
6
8
19
80
1
Sp
in
e
al
b
ic
an
s
A
m
p
h
o
te
ri
ci
n
B
+
fl
u
cy
to
si
n
e
R
e
so
lv
e
d
B
e
ra
n
t6
9
19
79
1
M
u
lt
ip
le
b
o
n
e
s
—
Fl
u
cy
to
si
n
e
R
e
so
lv
e
d
B
ri
ll
7
0
19
79
4
Lo
n
g
b
o
n
e
m
e
ta
p
h
ys
e
s,
il
ia
c
b
o
n
e
s,
cl
av
ic
le
s,
an
d
sp
in
e
al
b
ic
an
s
—
H
e
al
e
d
,
2
w
it
h
se
q
u
e
la
e
Sv
ir
sk
y-
Fe
in
7
1
19
79
2
—
tr
o
p
ic
al
is
—
—
Fr
e
d
e
ri
ck
so
n
7
2
19
78
1
V
e
rt
e
b
ra
l
p
ar
ap
si
lo
si
s
—
—
M
e
b
e
rg
7
3
19
77
1
—
—
M
ic
o
n
az
o
le
+
am
p
h
o
te
ri
ci
n
B
G
o
o
d
N
o
t
re
p
o
rt
e
d
/n
o
t
fo
u
n
d
.Miller’s review, 16 new cases have been reported
(see Table 1).Discussion
Candida albicans is a saprophytic microorganism
that may be isolated from skin and various mucus
membranes in healthy individuals. Alterations of
human flora, disruption of mucocutaneous mem-
branes, leukopenia, and reduced cell-mediated
immunity may predispose to fungal infection.6 Can-
dida osteomyelitis is one of the less frequent mani-
festations of invasive candidiasis. This condition
however carries significant morbidity, particularly
when its diagnosis is delayed by lack of recognition
of Candida spp as a potential bone pathogen. Osteo-
myelitis with Candida and other fungal species may
occur in patients who have severely compromized
host-defense mechanisms or who are receiving long-
standing intravenous therapy or central parenteral
nutrition.1 Osteomyelitis due to Candida species
can occur following either hematogenous dissemi-
nation or direct traumatic inoculation. Limited data
are available regarding the incidence of candidal
osteomyelitis. This entity has been reported in
organ transplant patients,6 in bone marrow trans-
plant recipients,9 intravenous drug addicts,8 and
severely ill patients with multiorgan failure.2,10,43
The pathogenesis in all instances is similar. A breach
in the normal mucocutaneous barrier in a patient on
antibiotics or immunosuppression becomes a portal
of entry for Candida and, following an episode of
fungemia, Candida can localize in any deep tissue.
The patient reported here had a past history of non-
rheumathoid arthritis, had neither used steroids,
cytostatic drugs nor received antibiotic treatment.
The pathogenesis of her disease cannot be
explained by any of these mechanisms.
Candida infection develops as a manifestation of
systemic candidemia in most cases. Factors that
predispose to systemic infection with this agent
include immunosuppression during the course of
anti-cancer therapy, organ transplantation, parent-
eral hyperalimentation, indwelling arterial/venous
catheters, intravenous drug addiction, diabetes,
broad-spectrum antibiotic therapy, HIV infection,
corticosteroid therapy, and myeloperoxidase defi-
ciency. Direct implantation of Candida is a very rare
cause. The usual species involved is Candida albi-
cans, although examples of infection with C. tropi-
calis, C. paratropicalis, and C. guilliermondii have
been reported.33
Virtually any bone can be involved, but vertebrae
are most commonly affected following an episode
of candidemia. A previous review found a report of
312 F. Arias et al.44 sites of osteomyelitis in 37 patients: 19 (43%) in
vertebrae, 68% of these in the lumbar spine, nine in
long bones, eight in the sternum, and eight in other
bones.6,10 In this review, the most common sites
were also spine and sternum, only three in long
bones, although in many cases the location was in
different bones. In this case report the talus was the
affected bone.
There are no distinctive clinical or radiologic
characteristics indicative of the causative organ-
isms, only careful microscopical examination and
appropriate culture of biopsy material will permit
a correct diagnosis.1 Even when a bone culture yields
a pathogen, sometimes it is not considered as the
cause of the infection. The patient in this study had
previous reports of Candida, but a diagnosis of can-
didal osteomyelitis had been considered unlikely.
The specific Candida species should be identified
to guide therapy because invasive candidiasis
caused by species other than C. albicans is increas-
ing in frequency, and also antifungal susceptibilities
of C. albicans are variable.20,74 The role of anti-
fungal susceptibility testing is still unclear as large
clinical studies correlating in vitro susceptibilities
with clinical responses have not been reported.20
Involvement of unusual sites can sometimes cre-
ate problems in diagnosis. Needle biopsy is an
extremely useful diagnostic procedure with a yield
of results that are 25—100% positive. Open biopsy is
indicated as the ultimate diagnostic procedure.1
Treatment is based on antifungal chemotherapy
with or without surgical debridement; amphotericin
B is considered the drug of choice. There is no
evidence that flucytosine in combination with
amphotericin B is more effective than amphotericin
B alone in the treatment of Candida osteomyelitis.10
The use of flucytosine alone cannot be recom-
mended since resistant strains emerge rapidly dur-
ing treatment.7 Some investigators recommend an
amphotericin B dose of 1—1.5 g. In patients who are
unable to start or complete an adequate course of
amphotericin B, fluconazole seems to be a reason-
able alternative and has been successful in treating
this infection.43,73 The role of itraconazole is not
clear, but should be effective in many cases. Anti-
fungal susceptibility testing may help in deciding
which drug to use, but the interpretation of results
should be made with caution. How long the treat-
ment should continue has not yet been established.7
According to some authors, patients should be trea-
ted for two to four weeks after resolution of clinical
signs and symptoms of infection and when there is
microbiological evidence of eradication of the
infection. Others recommend that therapy should
continue for at least six to twelve months beyond
the resolution of clinical symptoms and signs ofinfection.6,7,74 Prompt evaluation of bone pain in
patients at risk of candidemia, early aspiration
biopsy, and aggressive debridement with combina-
tion antifungal therapy would be likely to improve
outcome and decrease hospital costs in such
patients.
It is thought that this is the first report in Vene-
zuela and the second in the international literature
of talus osteomyelitis due to Candida. In the patient
described, although Candida was the only agent
isolated in previous interventions, the diagnosis
of Candida osteomyelitis was ruled out because
there were no predisposing factors or previous
reports in the literature of this uncommon location.
Nevertheless, the consecutive isolation of Candida
and visualization of hyphae as well as blastoconi-
diae by special stains in subsequent bone samples
led to the conclusion of the etiologic relationship.
Treatment with fluconazole was started and the
improvement was evident. Two years later the
patient remained healthy, concluding that the diag-
nosis was correct and the treatment effective.
The diagnosis of bone infection caused by Can-
dida spp is not easy to establish. Blood cultures are
usually negative. Biopsy of the involved bone is
required to make a definitive diagnosis, and if ade-
quate tissue samples are sent to the laboratory,
cultures and special stains are usually positive.
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